Abivax Ratios (2021-2025) | ABVX

Ratios Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -791.78%-306.31%-563.66%130.71%-784.10%-922.70%-195.43%
EBIT Margin -825.10%-279.10%-512.24%142.06%-706.69%-886.14%-102.85%
EBITDA Margin -825.10%-279.10%-512.24%142.06%-706.69%-886.14%-102.85%
Operating Margin -825.10%-279.10%-512.24%142.06%-706.69%-886.14%-102.85%
Net Margin -791.78%-306.31%-563.66%130.71%-784.10%-922.70%-195.43%
FCF Margin -641.71%-396.59%-357.95%115.18%-497.59%-635.05%-90.85%
Efficiency
Assets Average 101.01M214.49M197.45M155.51M448.86M
Invested Capital 70.45M50.81M82.90M2.67M121.82M14.73M16.00M32.85M
Asset Utilization Ratio 0.000.040.040.20
Leverage & Solvency
Interest Coverage Ratio 10.575.015.92-1.277.028.590.87
Debt Ratio 0.100.660.240.100.180.230.320.05
Times Interest Earned 10.575.015.92-1.277.028.590.87
Valuation
Enterprise Value -69.44M-27.50M-280.96M-273.70M-275.75M-276.69M-157.98M-155.70M-73.11M-689.40M
Return Ratios
Return on Sales -7.92%-3.06%-5.64%1.31%-7.84%-9.23%-1.95%
Return on Capital Employed -2.19%-7.17%-0.68%
Return on Assets -1.01%-1.37%-0.74%